Role of activated astrocytes in neuronal damage: Potential links to HIV-1-associated dementia

Neurotoxicity Research

Volumn 7, Issue 3, 2005, Pages 183-192

  Deshpande, Muralidhar ^a   Zheng, Jialin ^b   Borgmann, Kathleen ^a   Persidsky, Raisa ^a   Wu, Li ^a   Schellpeper, Courtney ^a   Ghorpade, Anuja ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Astrocyte; Fas ligand (FasL); Glial inflammation; HIV 1 associated dementia (HAD); IL 1 activation; Neurodegeneration; Neurotoxicity

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CASPASE; DIAGNOSTIC AGENT; FAS LIGAND; FASLG PROTEIN, HUMAN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; INDOLE DERIVATIVE; INTERLEUKIN 1; INTERMEDIATE FILAMENT PROTEIN; MAP2 PROTEIN, HUMAN; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; NERVE PROTEIN; NESTIN; NEUROFILAMENT PROTEIN; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TUMOR NECROSIS FACTOR ALPHA;

ANALYSIS OF VARIANCE; APOPTOSIS; ARTICLE; ASTROCYTE; CELL COUNT; CELL CULTURE; COMPARATIVE STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG INTERACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; NERVE CELL; NICK END LABELING; PHYSIOLOGY;

ANALYSIS OF VARIANCE; APOPTOSIS; ASTROCYTES; CASPASES; CELL COUNT; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DRUG INTERACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FETUS; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INDOLES; INTERLEUKIN-1; INTERMEDIATE FILAMENT PROTEINS; MEMBRANE GLYCOPROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; NERVE TISSUE PROTEINS; NEUROFILAMENT PROTEINS; NEURONS; TETRAZOLIUM SALTS; THIAZOLES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 21744452314     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03036448     Document Type: Article

References (44)

1. Ahlemeyer B, S Kolker, Y Zhu, GF Hoffmann and J Krieglstein (2002) Increase in glutamate-induced neurotoxicity by activated astrocytes involves stimulation of protein kinase C. J. Neurochem. 82, 504-515.
2. Ahmed Z, AI Doward, G Pryce, DL Taylor, JM Pocock, JP Leonard, D Baker and ML Cuzner (2002) A role for caspase-1 and -3 in the pathology of experimental allergic encephalomyelitis: Inflammation versus degeneration. Am. J. Pathol. 161, 1577-1586.
3. Allan SM (2000) The role of pro- and antiinflammatory cytokines in neurodegeneration. Ann. NY Acad. Sci. 917, 84-93.
4. Aschner M (1998) Astrocytes as mediators of immune and inflammatory responses in the CNS. Neurotoxicology 19, 269-281.
5. Aschner M, JW Allen, HK Kimelberg, RM LoPachin and WJ Streit (1999) Glial cells in neurotoxicity development. Annu. Rev. Pharmacol. Toxicol. 39, 151-173.
6. Barbeito LH, M Pehar, P Cassina, MR Vargas, H Peluffo, L Viera, AG Estevez and JS Beckman (2004) A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res. Brain Res. Rev. 47, 263-274.
7. Bezzi P, M Domercq, L Brambilla, R Galli, D Schols, E De Clercq, A Vescovi, G Bagetta, G Kollias, J Meldolesi and A Volterra (2001) CXCR4-activated astrocyte glutamate release via TNFalpha: Amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4, 702-710.
8. Cao J, MM Semenova, VT Solovyan, J Han, ET Coffey and MJ Courtney (2004) Distinct requirements for p38alpha and c-Jun N-terminal kinase stress-activated protein kinases in different forms of apoptotic neuronal death. J. Biol. Chem. 279, 35903-35913.
9. Carlson NG, WA Wieggel, J Chen, A Bacchi, SW Rogers and LC Gahring (1999) Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J. Immunol. 163, 3963-3968.
10. Caruso C, MC Bottino, M Pampillo, D Pisera, G Jaita, B Duvilanski, A Seilicovich and M Lasaga (2004) Glutamate induces apoptosis in anterior pituitary cells through group II metabotropic glutamate receptor activation. Endocrinology 145, 4677-4684.
11. Chen Y and RA Swanson (2003) Astrocytes and brain injury. J. Cereb. Blood Flow Metab. 23, 137-149.
12. Cid C, JC Alvarez-Cermeno, I Regidor, J Plaza, M Salinas and A Alcazar (2003) Caspase inhibitors protect against neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients. J. Neuroimmunol. 136, 119-124.
13. Daniel V, C Susal, R Weimer, R Zimmermann, A Huth-Kuhne and G Opelz (2001) Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases. AIDS Res. Hum. Retroviruses 17, 329-335.
14. Dhandapani KM, M Hadman, L De Sevilla, MF Wade, VB Mahesh and DW Brann (2003) Astrocyte protection of neurons: Role of transforming growth factor-beta signaling via a c-Jun-AP-1 protective pathway. J. Biol. Chem. 278, 43329-43339.
15. Dittel BN (2000) Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Arch. Immunol. Ther. Exp. (Warsz.) 48, 381-388.
16. Dong Y and EN Benveniste (2001) Immune function of astrocytes. Glia 36, 180-190.
17. Dowling P, G Shang, S Raval, J Menonna, S Cook and W Husar (1996) Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184, 1513-1518.
18. Elovaara I, F Sabri, F Gray, I Alafuzoff and F Chiodi (1999) Upregulated expression of Fas and Fas ligand in brain through the spectrum of HIV-1 infection. Acta Neuropathol. (Berl.) 98, 355-362.
19. Gervais FG, R Singaraja, S Xanthoudakis, CA Gutekunst, BR Leavitt, M Metzler, AS Hackam, J Tam, JP Vaillancourt, V Houtzager, DM Rasper, S Roy, MR Hayden and DW Nicholson (2002) Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nat. Cell. Biol. 4, 95-105.
20. Ghorpade A, S Holter, K Borgmann, R Persidsky and L Wu (2003) HIV-1 and IL-1 beta regulate Fas ligand expression in human astrocytes through the NF-kappa B pathway. J. Neuroimmunol. 141, 141-149.
21. Hartmann A, JD Troadec, S Hunot, K Kikly, BA Faucheux, A Mouatt-Prigent, M Ruberg, Y Agid and EC Hirsch (2001) Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J. Neurosci. 21, 2247-2255.
22. Ivins KJ, PL Thornton, TT Rohn and CW Cotman (1999) Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8. Neurobiol. Dis. 6, 440-449.
23. Maschke M, O Kastrup, S Esser, B Ross, U Hengge and A Hufnagel (2000) Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J. Neurol. Neurosurg. Psychiatry 69, 376-380.
24. McArthur JC, N Haughey, S Gartner, K Conant, C Pardo, A Nath and N Sacktor (2003) Human immunodeficiency virus-associated dementia: An evolving disease. J. Neurovirol. 9, 205-221.
25. Meucci O and R Miller (1996) gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: Protective action of TGF-beta1. J. Neurosci. 16, 4080-4088.
26. Meyer R, R Weissert, R Diem, MK Storch, KL de Graaf, B Kramer and M Bahr (2001) Acute neuronal apoptosis in a rat model of multiple sclerosis. J. Neurosci. 21, 6214-6220.
27. Minagar A, P Shapshak, R Fujimura, R Ownby, M Heyes and C Eisdorfer (2002) The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J. Neurol. Sci. 202, 13-23.
28. Pehar M, P Cassina, MR Vargas, R Castellanos, L Viera, JS Beckman, AG Estevez and L Barbeito (2004) Astrocytic production of nerve growth factor in motor neuron apoptosis: Implications for amyotrophic lateral sclerosis. J. Neurochem. 89, 464-473.
29. Persidsky Y, J Limoges, R McComb, P Bock, T Baldwin, W Tyor, A Patil, HS Nottet, L Epstein, H Gelbard, E Flanagan, J Reinhard, SJ Pirruccello and HE Gendelman (1996) Human immunodeficiency virus encephalitis in SCID mice. Am. J. Pathol. 149, 1027-1053.
30. Persidsky Y, A Ghorpade, J Rasmussen, J Limoges, XJ Liu, M Stins, M Fiala, D Way, KS Kim, MH Witte, M Weinand, L Carhart and HE Gendelman (1999) Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155, 1599-1611.
31. Raoul C, AG Estevez, H Nishimune, DW Cleveland, O deLapeyriere, CE Henderson, G Haase and B Pettmann (2002) Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations. Neuron 35, 1067-1083.
32. Sabri F, K Titanji, A De Milito and F Chiodi (2003) Astrocyte activation and apoptosis: Their roles in the neuropathology of HIV infection. Brain Pathol. 13, 84-94.
33. Saez TE, M Pehar, M Vargas, L Barbeito and RB Maccioni (2004) Astrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons. In Vivo 18, 275-280.
34. Sporer B, U Koedel, FD Goebel and HW Pfister (2000) Increased levels of soluble Fas receptor and Fas ligand in the cerebrospinal fluid of HIV-infected patients. AIDS Res. Hum. Retroviruses 16, 221-226.
35. Strijbos PJ and NJ Rothwell (1995) Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: Involvement of nerve growth factor. J. Neurosci. 15, 3468-3474.
36. Su JH, AJ Anderson, DH Cribbs, C Tu, L Tong, P Kesslack and CW Cotman (2003) Fas and Fas ligand are associated with neuritic degeneration in the AD brain and participate in beta-amyloid-induced neuronal death. Neurobiol. Dis. 12, 182-193.
37. Suryadevara R, S Holter, K Borgmann, R Persidsky, C Labenz-Zink, Y Persidsky, HE Gendelman, L Wu and A Ghorpade (2003) Regulation of tissue inhibitor of metalloproteinase-1 by astro-cytes: Links to HIV-1 dementia. Glia 44, 47-56.
38. Tan HK, D Heywood, GS Ralph, A Bienemann, AH Baker and JB Uney (2003) Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons. Mol. Cell. Neurosci. 22, 98-106.
39. Tanaka J, K Toku, B Zhang, K Ishihara, M Sakanaka and N Maeda (1999) Astrocytes prevent neuronal death induced by reactive oxygen and nitrogen species. Glia 28, 85-96.
40. Tyor WR, JD Glass, JW Griffin, PS Becker, JC McArthur, L Bezman and DE Griffin (1992) Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31, 349-360.
41. Valcour VG, CM Shikuma, MR Watters and NC Sacktor (2004) Cognitive impairment in older HIV-1-seropositive individuals: Prevalence and potential mechanisms. Aids 18, Suppl. 1, S79-S86.
42. Viswanath V, Y Wu, R Boonplueang, S Chen, FF Stevenson, F Yantiri, L Yang, MF Beal and JK Andersen (2001) Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease. J. Neurosci. 21, 9519-9528.
43. Viviani B, S Bartesaghi, E Corsini, CL Galli and M Marinovich (2004) Cytokines role in neurodegenerative events. Toxicol. Lett. 149, 85-89.
44. Zheng J, A Ghorpade, D Niemann, RL Cotter, MR Thylin, L Epstein, JM Swartz, RB Shepard, X Liu, A Nukuna and HE Gendelman (1999) Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: Implications for human immunodeficiency virus type 1-associated dementia. J. Virol. 73, 8256-8267.